Today: 21 May 2026
Browse Category

NASDAQ:OPEN 3 February 2026 - 11 May 2026

Opendoor Stock Faces a Hard Profit Test as CEO Says Turnaround Is Working

Opendoor Stock Faces a Hard Profit Test as CEO Says Turnaround Is Working

Opendoor shares fell 2.6% to $4.88 Monday after the company reported a first-quarter net loss of $173 million, more than double the previous year. Revenue dropped to $720 million from $1.15 billion, while home inventory was cut by over half. CEO Kaz Nejatian said resale speed improved and aged inventory declined. The company aims for breakeven adjusted EBITDA in the second quarter.
11 May 2026
··
Opendoor Stock Just Got a Hard Profit Test After Q1 Loss Widened

Opendoor Stock Just Got a Hard Profit Test After Q1 Loss Widened

Opendoor Technologies reported a wider first-quarter net loss of $173 million and revenue fell to $720 million, as homes sold dropped to 1,921. The company expects second-quarter adjusted EBITDA to be near break-even and forecasts revenue to rise about 25% from the first quarter. Shares last traded at $5.01, down 31 cents. Gross margin improved to 10.0%, and aged inventory fell to 10%.
10 May 2026
··
Opendoor Q1 Earnings Beat Wall Street — But OPEN Stock’s Bigger Test Starts Now

Opendoor Q1 Earnings Beat Wall Street — But OPEN Stock’s Bigger Test Starts Now

Opendoor’s first-quarter revenue reached $720 million, beating analyst estimates but dropping 38% from a year ago. The company’s net loss widened to $173 million, or 18 cents per share. CEO Kaz Nejatian cited faster home resales and improved inventory, but high mortgage rates continue to weigh on sales. Opendoor expects second-quarter revenue to grow about 25% from the first quarter.
7 May 2026
···
Opendoor Technologies Stock Keeps Climbing as Earnings Test Looms

Opendoor Technologies Stock Keeps Climbing as Earnings Test Looms

Opendoor Technologies shares rose 0.8% to $5.50 Wednesday morning, continuing a rebound ahead of first-quarter results due May 7. The stock is up from $4.51 on April 14. The company will replace its usual earnings call with a video "Financial Open House" for live shareholder questions. Wall Street remains divided on Opendoor's path to profitability as investors watch for improved unit economics.
22 April 2026
···
Why Opendoor Technologies (OPEN) Stock Is Falling Today as Mortgage Rates Cloud Spring Housing

Why Opendoor Technologies (OPEN) Stock Is Falling Today as Mortgage Rates Cloud Spring Housing

Opendoor shares fell about 2% to $5.09 in midday trading Tuesday, tracking declines in housing-linked stocks as mortgage rates hit 6.22%, the highest since December. The company projected a 10% sequential drop in first-quarter revenue and continued adjusted EBITDA losses. Management still targets breakeven adjusted net income by end-2026 despite weak market conditions.
24 March 2026
··
Opendoor Technologies Stock Price Jumps Nearly 6%—What Drove OPEN Higher as Housing Data Stayed Weak

Opendoor Technologies Stock Price Jumps Nearly 6%—What Drove OPEN Higher as Housing Data Stayed Weak

Opendoor Technologies shares jumped nearly 6% to $5.21 Monday, outpacing gains in other housing stocks as Wall Street rallied after President Trump postponed strikes on Iranian power plants. The company reported a $1.096 billion fourth-quarter loss, including a $933 million debt charge, and ended 2025 with $925 million in homes on its books. Mortgage rates rose to 6.22% last week, keeping the housing market sluggish.
23 March 2026
··
Opendoor Technologies Stock Price Drops as Mortgage Rates Hit 3-Month High, Home Sales Slide

Opendoor Technologies Stock Price Drops as Mortgage Rates Hit 3-Month High, Home Sales Slide

Opendoor Technologies shares fell 2.6% to $5.14 on Thursday, valuing the company at about $5.9 billion, as U.S. 30-year mortgage rates climbed to 6.22%, the highest since December. New-home sales dropped 17.6% in January to a 16-month low. Opendoor warned first-quarter revenue would likely fall 10% from the prior quarter, with adjusted EBITDA losses in the low-to-mid $30 million range.
20 March 2026
··
Opendoor Technologies Stock Price Falls as Fed Signals Rates May Stay High

Opendoor Technologies Stock Price Falls as Fed Signals Rates May Stay High

Opendoor Technologies shares dropped 5.0% to $5.28 after the Federal Reserve held rates steady and U.S. stocks declined. The company’s model faces pressure as high borrowing costs persist and resale times lengthen. Offerpad Solutions also fell 5.7%. Opendoor warned in its annual report that settling convertible notes could strain liquidity or dilute shareholders.
19 March 2026
····
Opendoor Technologies (OPEN) Stock Price Rebounds After Selloff as Mortgage Rates Rise Again

Opendoor Technologies (OPEN) Stock Price Rebounds After Selloff as Mortgage Rates Rise Again

Opendoor shares rose 2.4% to $4.96 Friday morning, rebounding after a previous drop. The move came as mortgage rates climbed to 6.11% and single-family housing starts fell 2.8% in January. Opendoor reported a $1.096 billion net loss last quarter but increased home purchases and faster sales. Senate passed a housing bill Thursday, but it awaits House approval.
13 March 2026
·····
Opendoor Stock Falls 6% as Rising Rate Fears, Weak Housing Data Hit OPEN Shares

Opendoor Stock Falls 6% as Rising Rate Fears, Weak Housing Data Hit OPEN Shares

Opendoor Technologies shares dropped 6% to $4.94 in late-morning Nasdaq trading Thursday after opening at $5.19. The decline followed weaker U.S. housing starts and a delay in expected Fed rate cuts, with the Nasdaq Composite down 1.38%. Opendoor reported a $1.1 billion net loss for 2025 and ended the year holding 2,867 homes worth $925 million. Peers Zillow and Offerpad also traded lower.
12 March 2026
··
Opendoor Stock Price Rises on Fresh Growth Signal as 4.99% Mortgage Draws Scrutiny

Opendoor Stock Price Rises on Fresh Growth Signal as 4.99% Mortgage Draws Scrutiny

Opendoor Technologies shares climbed 1.3% to $5.08 after its tracker showed weekly home acquisition contracts up 12%. The company’s stock outperformed Rocket Companies and Zillow, which both declined. Opendoor reported a $1.1 billion net loss last quarter but said homes purchased rose 46% from the prior period. CEO Kaz Nejatian said its 4.99% 30-year mortgage offer is still in beta.
11 March 2026
··
Opendoor Stock Swings After 4.99% Mortgage Offer Raises Fresh 2026 Profit Questions

Opendoor Stock Swings After 4.99% Mortgage Offer Raises Fresh 2026 Profit Questions

Opendoor Technologies shares fluctuated Monday as the company launched a 4.99% mortgage offer, below the 6% U.S. average. The rate applies only to buyers on its platform and is in beta, CEO Kaz Nejatian said. Opendoor reported a $1.3 billion net loss for 2025 and $1.1 billion in asset-backed debt. Analysts flagged risks to margins if home prices fall or funding remains expensive.
9 March 2026
··
Opendoor stock edges up in premarket after 5% slide as UBS hikes target ahead of earnings

Opendoor stock edges up in premarket after 5% slide as UBS hikes target ahead of earnings

Opendoor shares rose 0.8% to $4.73 in premarket trading Wednesday after a 5.1% drop Tuesday on heavy volume. UBS raised its price target to $5 but kept a neutral rating. Investors are awaiting Opendoor’s Feb. 19 earnings and webcast, with focus on cash use, margins, and inventory. S&P 500 futures edged up 0.1% ahead of a delayed U.S. jobs report.
11 February 2026
··
Opendoor stock drops 5% after mortgage-demand data; Feb 19 results loom

Opendoor stock drops 5% after mortgage-demand data; Feb 19 results loom

Opendoor shares fell about 5% to $4.86 in late morning trading Wednesday after U.S. mortgage applications dropped 8.9% last week. Purchase applications fell 14% as Winter Storm Fern hit much of the country. Opendoor will report earnings and hold a “Financial Open House” event on Feb. 19. Other real estate stocks, including Zillow and Offerpad, also traded lower.
4 February 2026
···
1 2 3 … 6

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop